Svas Biosana Future Growth
Future criteria checks 3/6
Svas Biosana is forecast to grow earnings and revenue by 13% and 4% per annum respectively while EPS is expected to grow by 1.8% per annum.
Key information
13.0%
Earnings growth rate
1.8%
EPS growth rate
| Medical Equipment earnings growth | 18.6% |
| Revenue growth rate | 4.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 12 Nov 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 136 | 8 | 6 | 13 | 1 |
| 12/31/2025 | 129 | 7 | -3 | 6 | 1 |
| 12/31/2024 | 123 | 6 | 4 | 13 | 1 |
| 6/30/2024 | 124 | 5 | 0 | 6 | N/A |
| 3/31/2024 | 123 | 5 | -1 | 5 | N/A |
| 12/31/2023 | 122 | 5 | -2 | 4 | N/A |
| 9/30/2023 | 117 | 5 | 2 | 7 | N/A |
| 6/30/2023 | 112 | 4 | 5 | 9 | N/A |
| 3/31/2023 | 106 | 4 | 2 | 7 | N/A |
| 12/31/2022 | 100 | 4 | 0 | 5 | N/A |
| 9/30/2022 | 94 | 3 | -6 | 0 | N/A |
| 6/30/2022 | 88 | 3 | -13 | -5 | N/A |
| 3/31/2022 | 85 | 3 | -8 | -1 | N/A |
| 12/31/2021 | 82 | 3 | -3 | 3 | N/A |
| 9/30/2021 | 80 | 3 | 2 | 6 | N/A |
| 6/30/2021 | 79 | 3 | 7 | 9 | N/A |
| 3/31/2021 | 78 | 3 | 8 | 10 | N/A |
| 12/31/2020 | 77 | 3 | 10 | 11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SVS's forecast earnings growth (13% per year) is above the savings rate (2.5%).
Earnings vs Market: SVS's earnings (13% per year) are forecast to grow faster than the Italian market (7.2% per year).
High Growth Earnings: SVS's earnings are forecast to grow, but not significantly.
Revenue vs Market: SVS's revenue (4% per year) is forecast to grow faster than the Italian market (3.9% per year).
High Growth Revenue: SVS's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SVS's Return on Equity is forecast to be high in 3 years time